PTC Therapeutics

PTC's brain-delivered gene therapy gets US nod for rare genetic disorder
First Word Pharma
Thu, 11/14/24 - 09:59 am
PTC Therapeutics
FDA
Kebilidi
AADC deficiency
PTC Therapeutics Faces Setback on Translarna Approval
Tip Ranks
Fri, 10/18/24 - 11:31 am
PTC Therapeutics
EMA
Europe
Translarna
Duchenne Muscular Dystrophy
PTC puts Friedreich ataxia drug's past failures in the rearview with long-term data drop
Fierce Biotech
Tue, 10/8/24 - 11:12 am
PTC Therapeutics
Friedreich’s ataxia
vatiquinone
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Wed, 10/2/24 - 11:24 am
FDA
Bridge Bio
acoramidis
AstraZeneca
Daiichi Sankyo
Dato-DXd
Vertex Pharmaceuticals
Vanza Triple
PTC Therapeutics
Upstaza
Bristol Myers Squibb
Opdivo
PTC Reports Positive Phase II Huntington’s Data, FDA Lifts Partial Clinical Hold
BioSpace
Thu, 06/20/24 - 06:00 pm
PTC Therapeutics
Huntington's disease
PTC518
clinical trials
3rd time's the charm? PTC will get another chance to keep Translarna's European marketing authorization
Fierce Pharma
Mon, 05/20/24 - 05:46 pm
PTC Therapeutics
Translarna
Europe
PTC's re-examination bid for DMD drug Translarna falls short in Europe
Fierce Pharma
Fri, 01/26/24 - 11:10 am
PTC Therapeutics
EMA
Europe
Translarna
DMD
PTC's plans crash into regulatory reality as FDA demands data on 2 candidates, delaying filing
Fierce Biotech
Fri, 10/27/23 - 11:49 am
PTC Therapeutics
FDA
Friedreich's Ataxia
PTC to sell spinal muscular atrophy drug royalties for $1B
BioPharma Dive
Thu, 10/19/23 - 11:34 am
PTC Therapeutics
spinal muscular atrophy
Evrysdi
Royalty Pharma
PTC deepens layoffs as DMD drug faces loss of authorization across Europe
Fierce Biotech
Fri, 09/29/23 - 10:19 am
PTC Therapeutics
DMD
layoffs
Europe
Translarna
After FDA setback, PTC Therapeutics' DMD drug Translarna faces possible market withdrawal in Europe
Fierce Pharma
Fri, 09/15/23 - 11:49 am
PTC Therapeutics
DMD
Translarna
Europe
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
BioSpace
Wed, 05/31/23 - 11:15 am
layoffs
Rain Oncology
Takeda
PTC Therapeutics
Affimed
Urovant Sciences
Roche
Novavax
Gossamer Bio
Bristol Myers Squibb
ADC Therapeutics
PTC Cuts Early-Stage Pipeline but Pushes Forward on FA Drug After Phase III Flop
BioSpace
Wed, 05/24/23 - 06:42 pm
PTC Therapeutics
Friedreich's Ataxia
clinical trials
vatiquinone
PTC, chasing BioMarin, posts phase 3 rare disease win but fails to silence skeptics
Fierce Biotech
Thu, 05/18/23 - 10:59 am
PTC Therapeutics
Biomarin
PKU
clinical trials
Biotech heads towards big catalysts
EP Vantage
Tue, 03/28/23 - 10:24 am
biotech
clinical trials
Alnylam Pharmaceuticals
Arcus Biosciences
Argenx
Arrowhead Pharmaceuticals
Axsome Therapeutics
Bavarian Nordic
FibroGen
Gilead Sciences
Incyte
Morphic Therapeutic
PTC Therapeutics
Syndax Pharmaceuticals
Travere Therapeutics
Vaxcyte
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
Sun, 03/26/23 - 03:44 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Sun, 03/26/23 - 03:36 pm
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
PTC Therapeutics CEO Stuart Peltz to retire after 25 years
NASDAQ.com
Fri, 03/24/23 - 11:44 am
Pharma CEOs
PTC Therapeutics
Stuart Peltz
Promising gene therapy delivers treatment directly to brain
Stat
Tue, 01/24/23 - 06:11 pm
gene therapy
brain
drug delivery
PTC Therapeutics
Huntington's Disease Continues to Baffle Biopharma
BioSpace
Thu, 11/17/22 - 11:28 pm
Huntington's disease
Triplet Therapeutics
PTC Therapeutics

Pages